IL6 and Alzheimer disease: Luteolin significantly inhibited the IgE levels and reduced the oxidative stress and inflammatory mediators including IL-1β, IL-6, TNF-α, IFN-γ, IL-4, IL-33, IL-8, and IL-17A in murine and canine AD models [178,179].